Literature DB >> 18556319

Commentary: Controversies in SIGN guidance on management of invasive meningococcal disease in children and young people.

David Isaacs1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18556319      PMCID： PMC2427107          DOI： 10.1136/bmj.a240

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  The incidence and mortality for meningococcal disease associated with area deprivation: an ecological study of hospital episode statistics.

Authors:  R S Heyderman; Y Ben-Shlomo; C A Brennan; M Somerset
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

2.  Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery.

Authors:  R Booy; P Habibi; S Nadel; C de Munter; J Britto; A Morrison; M Levin
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

3.  Recognising serious illness in feverish young children in primary care.

Authors:  Anthony Harnden
Journal:  BMJ       Date:  2007-09-01

4.  Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

Authors:  Stephen J Gray; Caroline L Trotter; Mary E Ramsay; Malcolm Guiver; Andrew J Fox; Raymond Borrow; Richard H Mallard; Edward B Kaczmarski
Journal:  J Med Microbiol       Date:  2006-07       Impact factor: 2.472

5.  The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases.

Authors:  Nelly Ninis; Claire Phillips; Linda Bailey; Jon I Pollock; Simon Nadel; Joseph Britto; Ian Maconochie; Andrew Winrow; Pietro G Coen; Robert Booy; Michael Levin
Journal:  BMJ       Date:  2005-06-25

6.  Clinical recognition of meningococcal disease in children and adolescents.

Authors:  Matthew J Thompson; Nelly Ninis; Rafael Perera; Richard Mayon-White; Claire Phillips; Linda Bailey; Anthony Harnden; David Mant; Michael Levin
Journal:  Lancet       Date:  2006-02-04       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.